The key technology platforms are composed of advanced extraction, isolation and structure elucidation of marker compounds and/or active components from drug substances (including animal, plant and synthetic sources). It offers a wide range of technical services and conducts in-house product development. In accordance with the requirements set forth by the FDA, Shanghai SiniWest has established a whole series of technical procedures concerning herbal recipe selection, chemical and extraction process study, quality standards, pilot production and plantation control (GAP), etc. It has also acquired some practical experience in product development. Using its overall technical capabilities, Shanghai SiniWest Pharmaceutical & Chemical Technology Co., Ltd. successfully developed a number of techniques relative to bulk drug impurity isolation and structure elucidation. It is essential to have high-quality standard compounds in the development of both botanical drugs and nutraceuticals from natural sources. In addition, standard compounds are indispensable in TCM pharmacokinetics and drug metabolic studies. Therefore, Shanghai SiniWest has prepared a large number of botanical drug standards for internal research use as well as external sales. Through collaboration with other research institutions, Shanghai SiniWest Pharmaceutical & Chemical Technology Co., Ltd. has started a feasibility study involving detection of certain metabolites in human or animal serum following TCM administration, with an aim toward the identification of active component(s), active part(s) and their effective combination. This may pave a way for new drug discovery.